Rockwood Achieves Another First in Treating Heart Disease

Rockwood Another First in Treating Heart Disease

Rockwood Clinic's Heart and Vascular Unit have broken new ground in the Inland Northwest for ischemic heart disease patients. Rockwood's Clinic has become the first in the area to perform a procedure using a bioresorbable coronary stent.Rockwood Clinic's Heart and Vascular Unit have broken new ground in the Inland Northwest for ischemic heart disease patients. Rockwood's Clinic has become the first in the area to perform a procedure using a bioresorbable coronary stent.

The bioresorbable coronary stent is implanted in patients who suffer from coronary artery diseases. Around the globe, coronary artery disease is the leading cause of death and it affects 15 million people in the United States.

Similar to its metal predecessor, the bioresorbable stent keeps a clogged artery open. However, the new stent is made of naturally dissolving material that disappears once the artery is opened, allowing the blood to flow freely after about three years. Metal stents, on the other hand, are implanted permanently and restrict vessel motion thereafter.

"Bioresorbable stents are a great addition to our treatment options for appropriately sized vessels," Interventional Cardiologist, Dr. Ellie Mueller, the first physician in Spokane to implant the stent, explained. "It is one of the new cutting edge technologies available for appropriate patients with ischemic heart disease, and we are happy to be able to offer it to our patients."

To date, Rockwood's Heart and Vascular Service has performed several procedures using the bioresorbable stent, including the first procedure done in mid-March.

Back To News and Events Home

Explore Our Site